Kasireddy TR, Yukselen Z, Muthyala A, Bansal K, Dasari M, Kumar PA, Anugu VR, Majmundar V, Nakhla M, Sharma G, Nasir K, Warraich HJ, Ganatra S, Dani SS
Abstract
Psychosocial risk factors (PSRFs) have emerged as crucial nontraditional risk factors affect-ing outcomes in patients with heart failure (HF). There is a paucity of data studying these risk factors in HF nationally. Additionally, whether the COVID-19 pan-demic impacted outcomes remains unexplored, given the increased psychosocial risk during these times. Our objective is to assess the impact of PSRFs on the outcomes of HF and their comparison across non-COVID-19 and COVID-19 eras. Patients with a diag-nosis of HF were selected using the 2019-2020 Nation-wide Readmissions Database. Two cohorts were created based on the presence or absence of PSRFs and compared across non-COVID-19 and COVID-19 eras. We examined the association using hierarchical multivariable logistic regression models. A total of 305,955 patients were included, of which 175,348 (57%) had PSRFs. Patients with PSRFs were younger, less likely to be female, and had a higher prevalence of cardiovascular risk factors. All-cause readmissions were higher in patients with PSRFs in both the eras. All-cause mortality [odds ratio, OR 1.15 (1.04-1.27), P = 0.005] and composite of MACE [OR 1.11 (1.06-1.16), P < 0.001] were higher in patients in the non-COVID-19 era. Compared to 2019, patients with PSRFs and HF in 2020 had significantly higher all -cause mortality [OR 1.13 (1.03-1.24), P = 0.009]; how-ever, the composite of MACE was comparable [OR 1.04 (1.00-1.09), P = 0.03]. In conclusion, the presence of PSRFs in patients with HF is associated with a significant increase in all-cause readmissions in COVID-19 and non-COVID-19 eras. The worse out-comes evident in the COVID-19 era highlights the importance of multidisciplinary care in this vulnerable population. (Curr Probl Cardiol 2023;48:101795.)
